Herren Sebastian C, Karau Melissa J, Koscianski Christina, Greenwood-Quaintance Kerryl E, Mandrekar Jayawant N, Wang Wen, Patel Robin
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Microbiol Spectr. 2025 Jun 3;13(6):e0237224. doi: 10.1128/spectrum.02372-24. Epub 2025 Apr 25.
Contezolid has activity against methicillin-resistant (MRSA), a common cause of orthopedic infection. In a rat model of foreign body osteomyelitis, 1.3 log cfu/g bone and 0.5 log cfu/k-wire reduction in MRSA was found in tibiae ( = 0.0186) and K-wires, respectively, of contezolid-treated compared to untreated rats. No MRSA was recovered from animals receiving rifampin alone or in combination with contezolid or vancomycin. There was no emergence of resistance to contezolid, vancomycin, or rifampin.
康替唑胺对耐甲氧西林金黄色葡萄球菌(MRSA)具有活性,MRSA是骨科感染的常见病因。在异物性骨髓炎大鼠模型中,与未治疗的大鼠相比,康替唑胺治疗组大鼠的胫骨和克氏针中MRSA分别减少了1.3 log cfu/g骨和0.5 log cfu/克氏针(P = 0.0186)。单独接受利福平或与康替唑胺或万古霉素联合使用的动物未分离出MRSA。未出现对康替唑胺、万古霉素或利福平的耐药性。